Loading...
Itamar Medical Ltd.
ITMR•NASDAQ
Healthcare
Medical - Devices
$30.87
$0.00(0.00%)

Over the last four quarters, Itamar Medical Ltd.'s revenue moved from $8.88M in Q2 2020 to $13.57M in Q3 2021. Operating income in Q3 2021 was -$5.66M, with a strong operating margin of -42%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Itamar Medical Ltd. remained robust at -$6.28M, reflecting operational efficiency. Net income dropped to -$7.98M, with an EPS of -$0.49. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan